<DOC>
	<DOCNO>NCT00434512</DOCNO>
	<brief_summary>GSK construct new HIV immunogen comprise conserved part HIV virus ( gag , pol nef ) . The principal objective study evaluate reactogenicity safety candidate vaccine without GSK proprietary adjuvant system three different dos evaluate CD4+ T-cell response term proportion responder antigens two week second vaccination .</brief_summary>
	<brief_title>Dose-ranging Study Evaluate Safety &amp; Immunogenicity HIV Vaccine 732461 Healthy HIV Seronegative Volunteers</brief_title>
	<detailed_description>This single center , observer-blind , randomize , dose-escalating , stagger study 6 group : 3 group 50 subject receive adjuvanted candidate vaccine , 3 different dos 3 group 10 subject receive non-adjuvanted candidate vaccine water injection , 3 different dos . The vaccination schedule 0-1 month . Blood sample collect 8 visit . The duration study approximately 14 month subject . Rationale Protocol Posting Amendment : The third vaccination cancel visit Month 7 postpone Month 9 . The Protocol Posting also update order comply FDA Amendment Act , Sep 2007 .</detailed_description>
	<mesh_term>Immunologic Deficiency Syndromes</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>A male female include 1840 year time first vaccination . Written inform consent obtain subject prior study procedure . Subjects investigator believe comply requirement protocol . Good general health without significant medical history , physical examination finding , clinically significant abnormal laboratory result . If subject female , must nonchildbearing potential , childbearing potential , must practice adequate contraception 30 day prior vaccination , negative pregnancy test continue precaution 2 month completion vaccination series . Negative antibody HIV1 , HIV2 negative HIV p24 antigen within 56 day ( 8 week ) prior enrolment . Subjects must willing accept HIV test result . Individuals elect receive test result enrol . Negative antiHBc Ab , HBsAg antiHCV Ab . Women pregnant breastfeeding . Subjects history , current , alcohol substance abuse . The subject high risk acquire HIV accord behavioural risk assessment questionnaire . Morbid obesity Previous inclusion HIV vaccines trial . Receipt live attenuate vaccine within 30 day enrolment . Receipt medically indicate subunit kill vaccine allergy treatment antigen injection within 14 day study vaccine administration . Use investigational nonregistered product ( drug vaccine ) study vaccine within 30 day precede first dose study vaccine , plan use study period . Prior receipt HIV1 vaccine placebo previous HIV vaccine trial . Receipt blood product 120 day prior HIV screen . Receipt immunoglobulin 120 day prior HIV screen . History serious adverse reaction include anaphylaxis relate symptom hive , respiratory difficulty , angioedema abdominal pain vaccine . History serious allergic reaction substance require hospitalization emergency medical care . History immunodeficiency autoimmune disease . History malignancy ( unless surgical excision follow sufficient observation period , least 5 year , give reasonable assurance sustain cure , estimate investigator , likely recur study period ) . Chronic administration immunosuppressant immunemodifying drug within six month prior first vaccination . History type I type II diabetes mellitus include case control diet alone . A subject past gestational diabetes eligible . Thyroid disease include history thyroidectomy diagnose require medication . A subject requiring thyroid medicine within past 12 month eligible . Acute disease time enrolment . Asthma require daily steroid long act Î² agonist prevention . Unstable asthma . Food wineinduced asthma . Known sensitivity sulfites aspirin . Bleeding disorder diagnose physician . A subject state easy bruise bleeding , carry formal diagnosis intramuscular ( IM ) injection blood draw without adverse experience eligible . History serious neurologic disorder seizure History major congenital defect History chronic fatigue syndrome fibromyalgia Splenectomy Hypertension . A subject hypertension eligible control medication document blood pressure less 150/100 . Any medical , psychiatric social condition , occupational responsibility , judgement investigator , would interfere serve contradiction adherence study protocol ability give inform consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>Gag</keyword>
	<keyword>vaccine</keyword>
	<keyword>adjuvant</keyword>
	<keyword>HIV</keyword>
	<keyword>Pol</keyword>
	<keyword>Nef</keyword>
</DOC>